| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005640740 |
| P356 | DOI | 10.1007/S00213-004-2077-2 |
| P698 | PubMed publication ID | 15551121 |
| P50 | author | Mitchell K.p. Lai | Q43120264 |
| Paul T. Francis | Q43923903 | ||
| P2093 | author name string | M M Esiri | |
| T Hope | |||
| C P Chen | |||
| S W Tsang | |||
| J Keene | |||
| J T Alder | |||
| P2860 | cites work | Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone | Q48269456 |
| The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia | Q48422201 | ||
| Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms | Q48440546 | ||
| A rapid radiochemical method for the determination of choline acetyltransferase | Q48478137 | ||
| Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells | Q48733614 | ||
| Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities | Q48864164 | ||
| Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. | Q53312706 | ||
| The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue | Q70091394 | ||
| Hallucinations, delusions, and cognitive decline in Alzheimer's disease | Q24672742 | ||
| “Mini-mental state” | Q25938989 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Behaviour changes in dementia. 1: Point of entry data of a prospective study | Q32149090 | ||
| Asymmetry of pathology in Alzheimer's disease | Q33629641 | ||
| Role of serotonin in memory impairment | Q33924606 | ||
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 | ||
| The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. | Q42487064 | ||
| Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease | Q44085385 | ||
| Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease | Q44438171 | ||
| The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities | Q44638941 | ||
| Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. | Q46875721 | ||
| Cholinergic deficits contribute to behavioral disturbance in patients with dementia | Q47585042 | ||
| Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes | Q47588776 | ||
| Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study | Q47604140 | ||
| Behaviour changes in dementia. 2: Are there behavioural syndromes? | Q47617528 | ||
| Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication | Q47633454 | ||
| Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease | Q48141692 | ||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| serotonin | Q167934 | ||
| P304 | page(s) | 673-677 | |
| P577 | publication date | 2004-11-18 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease | |
| P478 | volume | 179 |
| Q36739665 | A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders |
| Q48071023 | Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients |
| Q49562614 | Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline |
| Q42670442 | Branched-chain amino acids and Alzheimer's disease: a Mendelian randomization analysis |
| Q37230895 | Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice |
| Q60512507 | Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review) |
| Q37737296 | Current therapeutic targets for the treatment of Alzheimer's disease |
| Q48130307 | Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease |
| Q46913757 | Differentially disrupted functional connectivity of the subregions of the inferior parietal lobule in Alzheimer's disease |
| Q26749755 | Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT |
| Q99239419 | Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer's disease |
| Q46890765 | Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy |
| Q54957550 | Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder. |
| Q48143733 | Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons |
| Q43262807 | Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users |
| Q36724965 | Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease |
| Q28066691 | Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases |
| Q36020776 | Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease |
| Q36852606 | Polymorphism of the 5-HT(2A) receptor gene: association with stress-related indices in healthy middle-aged adults |
| Q30359998 | Psychedelics |
| Q37790804 | Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias |
| Q53393272 | Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology. |
| Q65002006 | Serotonergic system, cognition, and BPSD in Alzheimer's disease. |
| Q24554505 | Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients |
| Q47864065 | Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects. |
| Q47652062 | The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis. |
| Q37245282 | The serotonergic system and cognitive function |
| Q51019810 | Variations in 5-HT2A influence spatial cognitive abilities and working memory. |
| Q35014204 | Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease |